ORINF (Orion Oyj) Quality Rank


ORINF Orion Oyj ORINF
98 GF Score
Price $82.75
GF Value $80.88
! 3 Warning Signs
View Full Analysis

What is Orion Oyj Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Orion Oyj Quality Rank Related Terms

ORINF
98GF Score
Orion Oyj ORINF
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Orion Oyj (ORINF) Overvalued in 2026?

Based on GuruFocus' analysis, Orion Oyj stock appears to be overvalued. The current stock price of $82.75 is trading 2.3% above its estimated GF Value™ of $80.88.

Key valuation signals for ORINF:

  • Quality Rank:
  • GF Value™: $80.88 vs. price of $82.75 (2.3% above fair value)
  • GF Score™: 98/100 with 3 warning signs

No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orion Oyj Business Description

Address Orionintie 1, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
98GF Score

Get the complete analysis for ORINF

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$82.75
Price
$80.88
GF Value